The Womens Health medical devices market encompasses treatments for conditions that are particular to the adult female anatomy. This includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, as well as pelvic disorders such as female stress urinary incontinence. Moreover, there is a sub-segment of the female population that no longer desire to become pregnant, and seek permanent solutions to avoid conception.
Enquiry about report: http://www.researchbeam.com/womens-health-5eu-analysis-and-forecasts-market/enquire-about-report
Summary
In recent years, minimally invasive techniques and technologies have been developed to treat these conditions as alternatives to conventional surgery; these technologies are expected to see increased adoption in the coming years due to increased physician and patient awareness as well as an increasing number of women who are proactively seeking treatment for these embarrassing, and sometimes debilitating, conditions. However, recent lawsuits related to safety issues with some of these devices that are receiving widespread media attention, particularly in the urinary incontinence sling market, have caused some women to be skeptical of these newer technologies.
The technologies covered in this report include global endometrial devices, endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. The womens health market is determined for the five major European markets (5EU): France, Germany, Italy, Spain, and the UK. The report provides insights into the competitive landscape, the marketed and pipeline products, the current and emerging players and market analysis of the different device segments within the womens health market in the 5EU. The report also provides insight into the unmet needs and an understanding of physician perceptions of the market.
Scope
- Overview of womens health, including anatomy, epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
- Annualized total womens health market revenue from 2011-2021 including adoption patterns in the 5EU.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, and implications for the womens health market.
- Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and womens health devices in development.
- Analysis of the current and future market competition in the 5EU womens health market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Industry Overview
3.1 Overview
3.2 Indications
4 Unmet Needs
4.1 Overview
4.2 Endometrial Ablation/Resection Devices
5 Market Opportunity Analysis
5.1 Overview
5.2 Endometrial Ablation/Resection Devices
6 Market Drivers and Barriers
6.1 Endometrial Ablation/Resection
6.2 Uterine Fibroid Embolization Agents
7 Competitive Assessment
7.1 Overview
7.2 Classification Based on Features
8 Pipeline Assessment
8.1 Overview
8.2 Key Product Profiles
9 Clinical Trials to Watch
9.1 Overview
9.2 Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
10 Current and Future Players
10.1 Overview
10.2 Trends in Corporate Strategy
12 Appendix
12.1 Bibliography
12.2 Abbreviations
Source: http://www.researchbeam.com/womens-health-5eu-analysis-and-forecasts-market
Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Web: http://www.researchbeam.com
Email Us: help@researchbeam.com
